Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Fundam Clin Pharmacol ; 36(3): 501-508, 2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-34989025

RESUMEN

Gemfibrozil (GFZ) is a lipid-lowering drug with several other effects, such as antioxidant and anti-inflammatory activities. In the current study, chronic d-galactose treatment (d-gal, 150 mg/kg/day; i.p., 6 weeks) induced a model of accelerated aging in male mice and was used to study the behavioral, anti-oxidative, and neuroprotective effects of GFZ (100 mg/kg/day; p.o.). Anxiety-like behaviors were assessed using the elevated plus-maze while working memory was measured by spontaneous alternation in a Y-maze. Brain oxidative stress was determined by measuring malondialdehyde (MDA) levels, superoxide dismutase (SOD), and glutathione peroxidase (GPx) activities. Neuropathological evaluation of the brain with hematoxylin-eosin and Masson's trichrome staining was also performed. The results demonstrated that the anxious-like phenotype and the cognitive impairments observed in d-gal-treated mice could be prevented in those animals coadministered with GFZ. Besides, the decrease in SOD and GPx antioxidant enzymatic activities and increase of MDA levels were also prevented in the brains of d-gal plus GFZ treated mice. Preliminary hematoxylin-eosin staining also suggested neuroprotective effects of GFZ. The results of Masson's trichrome staining showed no evidence of fibrosis in brain sections of different experimental groups. The current data provide novel insights into GFZ in the d-galactose-induced aging mouse model that open promising future research lines to determine inflammatory mediators and cell signaling underlying these effects.


Asunto(s)
Galactosa , Fármacos Neuroprotectores , Envejecimiento , Animales , Antioxidantes/metabolismo , Antioxidantes/farmacología , Ansiedad/inducido químicamente , Ansiedad/tratamiento farmacológico , Ansiedad/prevención & control , Encéfalo , Eosina Amarillenta-(YS)/farmacología , Galactosa/farmacología , Gemfibrozilo/farmacología , Hematoxilina/farmacología , Hipolipemiantes/farmacología , Masculino , Malondialdehído , Aprendizaje por Laberinto , Ratones , Fármacos Neuroprotectores/farmacología , Estrés Oxidativo , Superóxido Dismutasa/metabolismo
2.
J Community Psychol ; 49(7): 2506-2516, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-34237163

RESUMEN

Quarantine, one of the most effective protection measures, plays an essential role in preventing the spread of infectious diseases. The coronavirus 2019 (COVID-19) pandemic, along with quarantine, can have devastating consequences for individuals' mental and social health. This study examined the psychosocial status of individuals during and after quarantine in the COVID-19 pandemic. This cross-sectional study was conducted on 714 individuals in the general population during (365) and 3 months after quarantine (349) in southeastern Iran. Data were collected using General Health Questionnaire (GHQ-28) and Generalized Anxiety Disorder 7-item (GAD-7) based on an online questionnaire. Data were collected from April 13 to April 20, 2020 (in quarantine) and 3 months later from August 20 to September 20, 2020. Psychological disorders in the quarantined population were significantly higher than that after quarantine. The risk of a mental disorder in the quarantined population was 1.54 times higher than that after quarantine. The results showed that quarantine is associated with a significant level of psychosocial disorders; therefore, interventions should be considered to reduce the effects of quarantine on the mental health of general population as a public health priority at the community level.


Asunto(s)
COVID-19/epidemiología , COVID-19/psicología , Adulto , Anciano , Ansiedad , Control de Enfermedades Transmisibles , Estudios Transversales , Femenino , Humanos , Irán/epidemiología , Masculino , Persona de Mediana Edad , Análisis de Regresión , Encuestas y Cuestionarios , Adulto Joven
3.
Life Sci ; 256: 117450, 2020 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-32087233

RESUMEN

Late treatment with tissue plasminogen activator (tPA) leads to reperfusion injury and poor outcome in ischemic stroke. We have recently shown the beneficial effects of local brain hypothermia after late thrombolysis. Herein, we investigated whether transient whole-body hypothermia was neuroprotective and could prevent the side effects of late tPA therapy at 5.5 h after embolic stroke. After induction of stroke, male rats were randomly assigned into four groups: Control, Hypothermia, tPA and Hypothermia+tPA. Hypothermia started at 5 h after embolic stroke and continued for 1 h. Thirty min after hypothermia, tPA was administrated. Infarct volume, brain edema, blood-brain barrier (BBB) and matrix metalloproteinase-9 (MMP-9) were assessed 48 h and neurological functions were assessed 24 and 48 hour post-stroke. Compared with the control or tPA groups, whole-body hypothermia decreased infarct volume (P < 0.01), BBB disruption (P < 0.05) and MMP-9 level (P < 0.05). However, compared with hypothermia alone a combination of hypothermia and tPA was more effective in reducing infarct volume. While hypothermia alone did not show any effect, its combination with tPA reduced brain edema (P < 0.05). Hypothermia alone or when combined with tPA decreased MMP-9 compared with control or tPA groups (P < 0.01). Although delayed tPA therapy exacerbated BBB integrity, general cooling hampered its leakage after late thrombolysis (P < 0.05). Moreover, only combination therapy significantly improved sensorimotor function as well as forelimb muscle strength at 24 or 48 h after stroke (P < 0.01). Transient whole-body hypothermia in combination with delayed thrombolysis therapy shows more neuroprotection and extends therapeutic time window of tPA up to 5.5 h.


Asunto(s)
Isquemia Encefálica/tratamiento farmacológico , Hipotermia Inducida/métodos , Accidente Cerebrovascular/tratamiento farmacológico , Activador de Tejido Plasminógeno/administración & dosificación , Animales , Barrera Hematoencefálica/metabolismo , Edema Encefálico/tratamiento farmacológico , Edema Encefálico/patología , Isquemia Encefálica/patología , Modelos Animales de Enfermedad , Embolia/tratamiento farmacológico , Embolia/patología , Fibrinolíticos/administración & dosificación , Fibrinolíticos/toxicidad , Masculino , Ratas , Ratas Wistar , Accidente Cerebrovascular/patología , Terapia Trombolítica/métodos , Factores de Tiempo , Activador de Tejido Plasminógeno/toxicidad
4.
Reprod Fertil Dev ; 31(6): 1049-1056, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30922438

RESUMEN

Cytokines are the main factors involved in the normal functions of the placenta and delivery process. The aim of this project was to compare serum levels of interleukin-8 (IL-8), IL-6, tumour necrosis factor α (TNF-α) and transforming growth factor ß (TGF-ß) in term and prolonged-pregnancy mothers and their neonates. This study was performed on 240 participants including 60 term and prolonged-pregnancy neonates and their corresponding mothers. Serum levels of IL-8, IL-6, TNF-α and TGF-ß were evaluated by the enzyme-linked immunosorbent assay technique. The results revealed that IL-8 serum levels were significantly lower in the prolonged-pregnancy mothers and their neonates when compared with term mothers and their neonates. Data analysis also revealed a negative correlation between TGF-ß and age of prolonged-pregnancy mothers. A poor positive correlation between IL-6 and head circumference of term neonates was also observed. IL-8 may play crucial roles in the process of on-time delivery and age may significantly affect TGF-ß production in prolonged-pregnancy mothers. Pro-inflammatory cytokines, such as IL-6, can also be considered as main factors involved in fetal growth.


Asunto(s)
Interleucina-8/sangre , Nacimiento a Término/sangre , Adulto , Femenino , Sangre Fetal , Humanos , Recién Nacido , Interleucina-6/sangre , Embarazo , Factor de Crecimiento Transformador beta/sangre , Factor de Necrosis Tumoral alfa/sangre
5.
Ren Fail ; 39(1): 519-525, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28558475

RESUMEN

PURPOSE: Pistacia vera is a plant of the family Anacardiaceae found in Central and West Asia. P. vera nut (Pistachio) possess multiple pharmacological effects such as antimicrobial, anti-hyperlipidemia, antioxidant and anti-inflammatory. This study is designed to evaluate the protective effect of the hydroalcoholic extract of pistachio on gentamicin-induced nephrotoxicity in rats. METHODS: Nephrotoxicity was induced in rats by intraperitoneal injection of gentamicin (100 mg/kg/day for 7 days). Hydroalcoholic extract of pistachio (10, 50 and 100 mg/kg/p.o) was administered for 7 days. The nephroprotective activity was evaluated by determining creatinine clearance, serum creatinine, urine volume, urine glucose and blood urea nitrogen (BUN) levels. The kidneys were processed for histopathological examinations and all specimens were examined for morphologic parameters involving tubular degeneration, tubular necrosis and tubule interstitial nephritis. RESULTS: Results showed a significant increase in the levels of serum creatinine, urine volume, urine glucose and BUN and decrease of creatinine clearance by gentamicin (GA) administration. Co-administration with pistachio extract showed reduction in the levels of serum creatinine, urine volume, urine glucose and BUN and increase of creatinine clearance in all doses but the most significant alteration was observed in doses of 100 mg/kg. Also, the nephroprotective effect of the GA was confirmed by the histological examination of the kidneys. CONCLUSION: The study revealed the nephroprotective effect of the hydroalcoholic extract of pistachio. These findings suggest that pistachio treatment may attenuate renal dysfunction and structural damage through the reduction of oxidative stress and inflammation in the kidney.


Asunto(s)
Antiinflamatorios/uso terapéutico , Antioxidantes/uso terapéutico , Enfermedades Renales/tratamiento farmacológico , Pistacia/química , Extractos Vegetales/uso terapéutico , Animales , Nitrógeno de la Urea Sanguínea , Creatinina/sangre , Gentamicinas/toxicidad , Humanos , Riñón , Enfermedades Renales/sangre , Enfermedades Renales/inducido químicamente , Pruebas de Función Renal , Masculino , Metanol/química , Nueces/química , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Urea/sangre
6.
Iran J Reprod Med ; 13(6): 345-50, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26330848

RESUMEN

BACKGROUND: It has been documented that cytokines play important roles in the induction of normal functions of the placenta. It has been hypothesized that abnormal expression of the cytokines may be associated with unsuccessful pregnancy. OBJECTIVE: The aim of this study was to compare the serum levels of interleukin-17A (IL-17A) and tumor growth factor (TGF-ß) in pre-term, term neonates, and their corresponding mothers. MATERIALS AND METHODS: This study was performed on 100 term and 60 pre-term neonates, and also on their corresponded mothers. Serum levels of IL-17A and TGF-ß were examined by enzyme linked immunosorbent assay (ELISA). RESULTS: Our results revealed that the serum levels of IL-17A were significantly decreased in pre-term neonates in comparison to full-term neonates. However, the serum levels of IL-17A in the mothers either with pre-term or full-term neonates were not different. Also the serum levels of TGF-ß were not changed in pre-term neonates and their mothers when compared with full-term neonates and their mothers, respectively. CONCLUSION: Based on these findings, it can be concluded that IL-17A may play crucial roles in induction of normal pregnancies and also probably participates in normal growth of fetus.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA